A Qualitative Study of Barriers to Medication-Taking Among People With Type 2 Diabetes Using the Theoretical Domains Framework

Author:

Vallis Michael1,Jin Susie2,Klimek-Abercrombie Agnieszka3,Ng Ginnie4ORCID,Ivers Noah M.5

Affiliation:

1. 1Family Medicine, Dalhousie University, Halifax, Nova Scotia, Canada

2. 2Consultant Pharmacist, Coburg, Ontario, Canada

3. 3Medical Affairs, Novo Nordisk Canada, Inc., Mississauga, Ontario, Canada

4. 4Real World Solutions, IQVIA Solutions Canada, Inc., Mississauga, Ontario, Canada

5. 5Department of Family Medicine, Women’s College Hospital and University of Toronto, Toronto, Ontario, Canada

Abstract

Objective We aimed to better understand the challenges related to type 2 diabetes medication-taking through Theoretical Domains Framework (TDF)-guided interviews with people with type 2 diabetes with varying degrees of medication-taking. Methods One-on-one qualitative interviews following a semistructured discussion guide informed by the TDF were conducted. Thirty people with type 2 diabetes in Canada were interviewed, with representation from across the country, of both sexes (47% female), of people with various diabetes durations (mean 12.9 ± 7.9 years), with different types of medication plans (n = 15 on polypharmacy), and with various medication-taking levels (n = 10 each for low-, medium-, and high-engagement groups). Results Themes related to medication-taking from interviews mapped to 12 of the 14 TDF theme domains, with the exclusion of the knowledge and skills domains. The most prominent domains, as determined by high-frequency themes or themes for which people with low and high medication-taking had contrasting perspectives, were 1) emotion; 2) memory, attention, and decision processes; 3) behavioral regulation; 4) beliefs about consequences; 5) goals; and 6) environmental context and resources. Conclusion Through our interviews, several areas of focus emerged that may help efforts to increase medication-taking. To validate these findings, future quantitative research is warranted to help support people with type 2 diabetes in overcoming psychological and behavioral barriers to medication-taking.

Funder

Novo Nordisk Canada

Publisher

American Diabetes Association

Reference32 articles.

1. Introduction;Diabetes Canada Clinical Practice Guidelines Expert Committee;Can J Diabetes,2018

2. Type 2 diabetes;Government of Canada

3. Pharmacologic glycemic management of type 2 diabetes in adults: 2020 update;Lipscombe;Can J Diabetes,2020

4. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors;Polonsky;Patient Prefer Adherence,2016

5. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus;Ho;Arch Intern Med,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3